Pulling SEC filings + quote and writing the call…

NMI Holdings, Inc.
Next earnings Jul 27, 2026 (after close) · consensus $1.31 EPS, $160M rev
Last earnings -5.9% on 2026-04-30
Profitable, fortress-balance-sheet mortgage insurer compounding ~11% EPS yet priced at 8.4x — cheap for the quality.
P/E (price / FY diluted EPS) 8.4 · FY2025 / current price
Quality fundamentals and an attractive price line up (~163% below fair value) — the rarer case where both the business and the entry look good.
NMIH is a high-quality private mortgage insurer that has compounded steadily through a tough rate environment: revenue rose every year from $485M (FY2021) to $706M (FY2025, +8.5% YoY) and net income from $231M to $389M (+8.0%), with diluted EPS up 11.1% to $4.92 thanks in part to a 3.1% lower share count from $105M of buybacks. The economics are exceptional for an insurer — 55.1% net margin, 15.0% ROE, and $419M of operating cash flow against just $6.8M of capex. The balance sheet is a fortress: liabilities/equity of only 0.48x, equity up 16.9% to $2.59B, and retained earnings up 24.6% to $1.97B as the in-force book ($221.4B primary IIF, $59.3B RIF per the 10-K) seasons and earns. The low $43.9M cash line is not a red flag for an insurer whose assets sit in an investment portfolio.
The stock is priced as if this consistency will break. At $41.22 the P/E is 8.4x trailing EPS and the company trades at roughly 1.2x book (market cap $3.13B vs. $2.59B equity) — a discount for a business earning a mid-teens ROE and returning capital. A modest re-rating to ~10x EPS plus continued buyback-aided EPS growth supports a price in the low-$50s, with the seasoning portfolio and high persistency in a high-rate world (borrowers keep paying MI rather than refinancing into a no-MI loan) providing a durable revenue base.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 29, 2026, 6:42 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $485M | $523M | $579M | $651M | $706M |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $231M | $293M | $322M | $360M | $389M |
| Diluted EPS | $2.65 | $3.39 | $3.84 | $4.43 | $4.92 |
| Net margin | 47.6% | 56.0% | 55.6% | 55.3% | 55.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting results: directors elected, routine shareholder votes ratified
Q1'26 10-Q: insured portfolio and net income keep growing, low leverage
Q1'26 earnings release; growth streak intact with double-digit EPS gains
Annual proxy: board slate, say-on-pay and auditor up for routine vote
FY25 10-K: $221.4B IIF, ROE 15%, $389M net income, $105M buybacks
FY25 10-K: $221.4B IIF, ROE 15%, $389M net income, $105M buybacks
FY25 earnings: net income $389M, EPS $4.92 up 11%, record results
Q3'25 10-Q: continued IIF growth and strong margins
Q3'25 earnings release continues steady premium and earnings growth
Sources: SEC EDGAR (CIK 0001547903, latest 10-Q filed 2026-05-01) · EODHD · Proprietary analysis · as of 6/29/2026, 10:42:59 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 1 sale
| 2026-05-19 | Montgomery Michael Curry Director | Sell | 1.55K @ $37.90 | $58.9K |
| 2026-05-14 | EMBLER MICHAEL J Director | Award | 4.51K | |
| 2026-05-14 | Montgomery Michael Curry Director | Award | 4.51K | |
| 2026-05-14 | SCHEID STEVEN Director | Award | 4.51K | |
| 2026-05-14 | McCreary Lynn S. Director | Award | 4.51K | |
| 2026-05-14 | Huskins Priya Cherian Director | Award | 4.51K | |
| 2026-05-14 | Erickson John C Director | Award | 4.51K | |
| 2026-05-14 | Agrawal Renu Director | Award | 4.51K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.